胰十二指肠切除术中减少失血的有益作用
该研究基于2001至2015年17家机构62名外科医生完成的5323例胰十二指肠切除术,分析术中失血量对围术期结局的影响。结果显示失血量与术中输血及不良结局呈剂量依赖相关,关键阈值为750 mL,并识别出部分可被外科医生调控的影响因素。
要点
- 失血量与术中输血及不良围术期结局呈剂量依赖相关,关键阈值为750 mL。
- 术中失血量中位数为400 mL,术中、术后及围术期输血率分别为15.8%、24.8%、37.2%。
- 增加失血的因素中38.7%的相对影响可能被外科医生调控。
核心结论
- 减少失血有助于减少胰十二指肠切除术中的术中输血并改善围术期结局。
- 针对影响估计失血量的可调控因素可能改善结局。
研究设计与样本
- 回顾性队列研究,纳入2001至2015年17家机构62名外科医生完成的5323例胰十二指肠切除术。
- 采用最优尺度法将估计失血量离散为0至300、301至750、751至1300及>1300 mL四组。
- 使用多因素回归调整患者、外科医生及机构变量,分析估计失血量与围术期结局的关联。
主要发现
- 估计失血量中位数为400 mL(四分位距250至600)。
- 术中、术后及围术期输血率分别为15.8%、24.8%、37.2%。
- 估计失血区间与术中输血呈剂量依赖相关(P<0.001),关键阈值为750 mL(8.14% vs 40.9%;P<0.001),但与术后输血无关。
- 失血量增加与不良围术期结局显著相关。
关键数值与推荐
- 增加估计失血量的因素包括跨吻合口支架置入、新辅助化疗、胰胃吻合重建、多器官或血管切除及手术时间延长,其中38.7%的相对影响可能被外科医生调控。
- 减少估计失血量的因素包括女性、小胰管、软腺体、微创入路、保留幽门、生物密封剂使用及机构年手术量≥67例,其中13.6%可能受外科医生影响。
临床怎么用
- 术中应关注估计失血量,尤其是达到750 mL阈值时,以降低术中输血需求。
- 可针对可调控因素(如吻合方式、支架置入、手术时间等)优化操作以减少失血。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to elucidate the impact of intraoperative blood loss on outcomes following pancreatoduodenectomy (PD). BACKGROUND: The negative impact of intraoperative blood loss on outcomes in PD has long been suspected but not well characterized, particularly those factors that may be within surgeons' control. METHODS: From 2001 to 2015, 5323 PDs were performed by 62 surgeons from 17 institutions. Estimated blood loss (EBL) was discretized (0 to 300, 301 to 750, 751 to 1300, and >1300 mL) using optimal scaling methodology. Multivariable regression, adjusted for patient, surgeon, and institutional variables, was used to identify associations between EBL and perioperative outcomes. Factors associated with both increased and decreased EBL were elucidated. The relative impact of surgeon-modifiable contributors was estimated through beta coefficient standardization. RESULTS: The median EBL of the series was 400 mL [interquartile range (IQR) 250 to 600]. Intra-, post-, and perioperative transfusion rates were 15.8%, 24.8%, and 37.2%, respectively. Progressive EBL zones correlated with intra- but not postoperative transfusion in a dose-dependent fashion (P < 0.001), with a key threshold of 750 mL EBL (8.14% vs 40.9%; P < 0.001). Increasing blood loss significantly correlated with poor perioperative outcomes. Factors associated with increased EBL were trans-anastomotic stent placement, neoadjuvant chemotherapy, pancreaticogastrostomy reconstruction, multiorgan or vascular resection, and elevated operative time, of which 38.7% of the relative impact was "potentially modifiable" by the surgeon. Conversely, female sex, small duct, soft gland, minimally invasive approach, pylorus-preservation, biological sealant use, and institutional volume (≥67/year) were associated with decreased EBL, of which 13.6% was potentially under the surgeon's influence. CONCLUSION: Minimizing blood loss contributes to fewer intraoperative transfusions and better perioperative outcomes for PD. Improvements might be achieved by targeting modifiable factors that influence EBL.
引用
- Seykora TF, Ecker BL, McMillan MT, et al. The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy. Ann Surg. 2019. PMID: 29489483. doi:10.1097/SLA.0000000000002714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。